Optometry

Philosophical differences abound between managers and physicians.

A trunk show is one of the most productive business strategies to generate revenue, excitement, and buzz for your dispensary.

Planned anisometropia in patients with long-standing diplopia who are undergoing bilateral cataract surgery can be a triple-win situation, providing clear uncorrected vision at both distance and near while simultaneously eliminating or reducing awareness of pre-existing double vision.

Nidek has received FDA 510(k) clearance for a non-mydriatic automated fundus camera (AFC-330) that it will market to the U.S. ophthalmology market and Marco Ophthalmic will market to the optometry market.

On April 20, Abbott Medical Optics announced that it had received FDA clearance for use of the 150-kHz iFS advanced femtosecond laser to create arcuate incisions during corneal surgery, including cataract surgery.

Independent medical practices continue to adopt electronic health record technology at an increasing rate.

Understanding the cause of elevated IOP in patients with uveitis is the basis for developing a rational treatment plan.

The premium sunglasses business is very trendy.

Leading refractive surgeons agree wavefront-guided ablation is a significant advance in laser vision correction, but have different opinions about its role in treating myopic eyes with low higher-order aberrations.

A record number of ophthalmologists hit the hallways on Capitol Hill last month to urge their legislators to protect Americans' access to eye care and boost funding for eye research.

The Association for Research in Vision and Ophthalmology closed its 2012 annual meeting with more than 12,500 participants – its largest attendance ever.

Using interferon alpha-2b systemically for the treatment of refractory uveitic cystoid macular edema may be helpful in carefully selected patients.

The corrections following phacoemulsification and IOL implantation that are achievable today are a far cry from those commanded in the 1970s when 20/40 corrected bilaterally was considered an accomplishment following implantation of the early IOLs.

Losing staff is a devastating experience.

As outgoing president of the ASCRS, Edward J. Holland, MD, can be recognized for a number of accomplishments and the introduction of several new initiatives.

As a rule, the latest and greatest new technology first becomes available to the haves in this world, and only much later, if at all, to the have-nots.

Adoption of electronic health record technology has been slow, particularly among ophthalmologists.

Many agents have been investigated in clinical trials for neuroprotection in glaucoma, but none has proven efficacy, and so IOP control continues to be the mainstay strategy for preventing glaucoma progression.

Epimacular brachytherapy was described as "interesting and encouraging" at the 2-year time point for treating exudative age-related macular degeneration that had been previously treated with anti-vascular endothelial growth factor injections.

Topical branded nonsteroidal anti-inflammatory drugs are safe to use in patients with evaporative dry eye syndrome and in those with meibomian gland dysfunction.

Results from randomized controlled clinical trials investigating populations covering the spectrum from ocular hypertension to advanced glaucoma provide clear evidence that for most patients, glaucoma is an IOP-sensitive optic neuropathy for which lowering IOP is effective in slowing or arresting progression.

Ophthalmologists should not order routine genetic tests for patients with common disorders like age-related macular degeneration until there are specific therapeutic interventions available to treat the disease based on the genetic information.

The acceleration of research focused on dry eye over the past several decades has led to an increase in knowledge regarding the pathophysiology of the disease.

Dry eye comes in a variety of guises and, once diagnosed, may require various therapeutic options.

The world of glaucoma management in 2012 is feeling the impact of not only a variety of challenges, but also new opportunities.